Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. Show more

1800 Aston Avenue, Carlsbad, CA, 92008, United States

Health Information Services
Healthcare

Market Cap

438.2M

52 Wk Range

$8.50 - $17.23

Previous Close

$16.05

Open

$16.07

Volume

114,686

Day Range

$15.76 - $16.43

Enterprise Value

370.9M

Cash

89.22M

Avg Qtr Burn

-7.358M

Insider Ownership

44.42%

Institutional Own.

40.31%

Qtr Updated

06/30/26


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date